These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 21840752)

  • 41. Plasma stromal cell-derived factor-1: host derived marker predictive of distant metastasis in breast cancer.
    Hassan S; Baccarelli A; Salvucci O; Basik M
    Clin Cancer Res; 2008 Jan; 14(2):446-54. PubMed ID: 18223219
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Correlation of EphA2 protein expression with clinicopathological characteristics and prognosis in laryngeal squamous cell carcinoma].
    Liu Y; Zhang X; Qiu YZ; Huang DH; Zhou XJ; Tan PQ; Cai GM; Dai YZ; Yu CY; Xiao JY; Tian YQ
    Zhonghua Zhong Liu Za Zhi; 2011 Mar; 33(3):197-201. PubMed ID: 21575519
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Elevated ZNF703 Protein Expression Is an Independent Unfavorable Prognostic Factor for Survival of the Patients with Head and Neck Squamous Cell Carcinoma.
    Yang H; Jiang WQ; Cao Y; Sun YA; Wei J; An X; Zhang YC; Song M; Wang SS; Yuan ZY; Peng RJ; Chen TH; Li LR; Shi YX
    Dis Markers; 2015; 2015():640263. PubMed ID: 26063961
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Distinctive clinicopathological associations of amplification of the cortactin gene at 11q13 in head and neck squamous cell carcinomas.
    Rodrigo JP; García-Carracedo D; García LA; Menéndez S; Allonca E; González MV; Fresno MF; Suárez C; García-Pedrero JM
    J Pathol; 2009 Mar; 217(4):516-23. PubMed ID: 18991334
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Safety and feasibility of every-other-week maintenance cetuximab after first-line chemotherapy in patients with recurrent or metastatic head and neck squamous cell cancer.
    Bossi P; Kornek G; Lanzetta G; Rozzi A; Füreder T; Locati L; Licitra L
    Head Neck; 2013 Oct; 35(10):1471-4. PubMed ID: 23042567
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Expression of insulin-like growth factor II mRNA-binding protein 3 in squamous cell carcinomas of the head and neck.
    Clauditz TS; Wang CJ; Gontarewicz A; Blessmann M; Tennstedt P; Borgmann K; Tribius S; Sauter G; Dalchow C; Knecht R; Münscher A; Wilczak W
    J Oral Pathol Med; 2013 Feb; 42(2):125-32. PubMed ID: 22643116
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Parotid metastasis--an independent prognostic factor for head and neck cutaneous squamous cell carcinoma.
    Ch'ng S; Maitra A; Lea R; Brasch H; Tan ST
    J Plast Reconstr Aesthet Surg; 2006; 59(12):1288-93. PubMed ID: 17113505
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Association of CXC chemokine receptor type 4 expression and clinicopathologic features in human vulvar cancer.
    Shiozaki T; Tabata T; Ma N; Yamawaki T; Motohashi T; Kondo E; Tanida K; Okugawa T; Ikeda T
    Int J Gynecol Cancer; 2013 Jul; 23(6):1111-7. PubMed ID: 23765204
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Increased expression of SDF-1/CXCR4 is associated with lymph node metastasis of invasive micropapillary carcinoma of the breast.
    Liu F; Lang R; Wei J; Fan Y; Cui L; Gu F; Guo X; Pringle GA; Zhang X; Fu L
    Histopathology; 2009 May; 54(6):741-50. PubMed ID: 19438749
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Lymph node metastases from cutaneous squamous cell carcinoma of the head and neck.
    Moore BA; Weber RS; Prieto V; El-Naggar A; Holsinger FC; Zhou X; Lee JJ; Lippman S; Clayman GL
    Laryngoscope; 2005 Sep; 115(9):1561-7. PubMed ID: 16148695
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Expression of stromal cell derived factor-1/CXCR4 biology axis in myelodysplastic syndromes].
    Zhang YZ; Da WM; Zhao DD; Zhao HF; Wu XX; Wang H
    Zhonghua Yi Xue Za Zhi; 2011 Dec; 91(46):3275-7. PubMed ID: 22333149
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prognostic impact of HER-2/neu expression on squamous head and neck carcinomas.
    Cavalot A; Martone T; Roggero N; Brondino G; Pagano M; Cortesina G
    Head Neck; 2007 Jul; 29(7):655-64. PubMed ID: 17315173
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Expression of CXCL12 and its receptor CXCR4 correlates with lymph node metastasis in submucosal esophageal cancer.
    Sasaki K; Natsugoe S; Ishigami S; Matsumoto M; Okumura H; Setoyama T; Uchikado Y; Kita Y; Tamotsu K; Sakurai T; Owaki T; Aikou T
    J Surg Oncol; 2008 Apr; 97(5):433-8. PubMed ID: 18176915
    [TBL] [Abstract][Full Text] [Related]  

  • 54. S-1 monotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck after progression on platinum-based chemotherapy.
    Yokota T; Onozawa Y; Boku N; Hamauchi S; Tsushima T; Taniguchi H; Todaka A; Machida N; Yamazaki K; Fukutomi A; Yasui H
    Jpn J Clin Oncol; 2011 Dec; 41(12):1351-7. PubMed ID: 21980053
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Construction of a CXCL12-KDEL fusion gene to inhibit head and neck squamous cell carcinoma metastasis by intracellular sequestration of CXCR4.
    Zhang W; Wang X; Yue K; Liu S; Liu X
    Biomed Res Int; 2015; 2015():195828. PubMed ID: 25866764
    [TBL] [Abstract][Full Text] [Related]  

  • 56. CXCR4: A New Player in an Old Scene?
    Knopf A; Fritsche MK; Li Y
    ORL J Otorhinolaryngol Relat Spec; 2017; 79(1-2):34-42. PubMed ID: 28231592
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Stromal cell-derived factor-1 inducing metastasis squamous cell carcinoma of head and neck induced via integrin ανβ3-CXC chemokine receptor 4/7 biological axis].
    Li P; Li WL; Qi JX
    Hua Xi Kou Qiang Yi Xue Za Zhi; 2018 Aug; 36(4):398-403. PubMed ID: 30182568
    [TBL] [Abstract][Full Text] [Related]  

  • 58. High CXCR4 expression in adenoid cystic carcinoma of the head and neck is associated with increased risk of locoregional recurrence.
    Klein Nulent TJW; van Es RJJ; Valstar MH; Smeele LE; Smit LA; Klein Gunnewiek R; Zuithoff NPA; de Keizer B; de Bree R; Willems SM
    J Clin Pathol; 2020 Aug; 73(8):476-482. PubMed ID: 31948995
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Infiltrating CD57+ inflammatory cells in head and neck squamous cell carcinoma: clinicopathological analysis and prognostic significance.
    Fraga CA; de Oliveira MV; Domingos PL; Botelho AC; Guimarães AL; Teixeira-Carvalho A; Correa-Oliveira R; De Paula AM
    Appl Immunohistochem Mol Morphol; 2012 May; 20(3):285-90. PubMed ID: 22505010
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Proteoglycan-based diversification of disease outcome in head and neck cancer patients identifies NG2/CSPG4 and syndecan-2 as unique relapse and overall survival predicting factors.
    Farnedi A; Rossi S; Bertani N; Gulli M; Silini EM; Mucignat MT; Poli T; Sesenna E; Lanfranco D; Montebugnoli L; Leonardi E; Marchetti C; Cocchi R; Ambrosini-Spaltro A; Foschini MP; Perris R
    BMC Cancer; 2015 May; 15():352. PubMed ID: 25935541
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.